GelMEDIX

Cambridge, MA · Founded 2020 · Privately Held (backing)

Developer of a light-activated biomaterial platform designed to bring innovation in ocular and regenerative therapies. GelMEDIX is based in Cambridge, MA and was founded in 2020. It was valued at $21 million at its seed round in Feb 2026, the last priced event on record. It has raised $30.7 million across 4 recorded rounds; the latest was a $747,000 seed round in Oct 2025.

PMV mark · valuation
$21.0M
Oct 2026
Priced at
its seed round
Feb 2026
Total raised
$30.7M
Last round
Seed Round
Oct 2025

Who backs GelMEDIX?

6 investors
InvestorType
Safar PartnersVenture capital
Beacon AngelsAngel
TiE Angels BostonVenture capital
Boston Harbor Angels—
EQx Fund—
HTL Biotechnology—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

GelMEDIX investors

6 investors are on record for GelMEDIX, including Safar Partners, Beacon Angels, TiE Angels Boston and Boston Harbor Angels. The seed round in Oct 2025 drew 5 investors.

Free account
More of GelMEDIX with a free account
  • ·Watch GelMEDIX: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 6 firms already write checks for companies like GelMEDIX. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View